These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 1337350

  • 1. The bactericidal activity of sparfloxacin.
    Lewin CS, Morrissey I, Smith JT.
    J Antimicrob Chemother; 1992 Nov; 30(5):625-32. PubMed ID: 1337350
    [Abstract] [Full Text] [Related]

  • 2. Bactericidal action of PD127,391, an enhanced spectrum quinolone.
    Lewin CS, Amyes SG.
    J Med Microbiol; 1990 Sep; 33(1):67-70. PubMed ID: 2231674
    [Abstract] [Full Text] [Related]

  • 3. Antibacterial activity of a 1,8-naphthyridine quinolone, PD 131628.
    Lewin CS.
    J Med Microbiol; 1992 May; 36(5):353-7. PubMed ID: 1316970
    [Abstract] [Full Text] [Related]

  • 4. Bactericidal activity of the new 4-quinolones DU-6859a and DV-7751a.
    Morrissey I, Smith JT.
    J Med Microbiol; 1995 Jul; 43(1):4-8. PubMed ID: 7608954
    [Abstract] [Full Text] [Related]

  • 5. Improved bactericidal activity of Q-35 against quinolone-resistant staphylococci.
    Ito T, Matsumoto M, Nishino T.
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1522-5. PubMed ID: 7492097
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Smith KR, Cobbs CG.
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):55-8. PubMed ID: 1314175
    [Abstract] [Full Text] [Related]

  • 7. Activity of sparfloxacin on Staphylococcus epidermidis attached to plastic catheters.
    Pascual A, García I, Ramirez de Arellano E, Perea EJ.
    J Antimicrob Chemother; 1995 Aug; 36(2):425-30. PubMed ID: 8522473
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms of action of quinolones against staphylococci and relationship with their in vitro bactericidal activity.
    Ramón MS, Cantón E, Pemán J, Pastor A, Martínez JP.
    Chemotherapy; 1999 Aug; 45(3):175-82. PubMed ID: 10224339
    [Abstract] [Full Text] [Related]

  • 9. [In vitro activity of sparfloxacin against methicillin-resistant staphylococci].
    Wallrauch C, Voss A, Milatovic D, Braveny I.
    Arzneimittelforschung; 1995 Jun; 45(6):723-5. PubMed ID: 7646580
    [Abstract] [Full Text] [Related]

  • 10. [In vitro short-term bactericidal activity and accumulation of NM394, the active metabolite of prulifloxacin, for Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa: comparison with ciprofloxacin, levofloxacin, and gatifloxacin].
    Shimizu M, Tabata M, Hara T, Araake M, Watabe H, Nishino T.
    Jpn J Antibiot; 2002 Dec; 55(6):791-9. PubMed ID: 12621733
    [Abstract] [Full Text] [Related]

  • 11. Bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditions.
    Cooper MA, Andrews JM, Wise R.
    J Antimicrob Chemother; 1991 Sep; 28(3):399-405. PubMed ID: 1660046
    [Abstract] [Full Text] [Related]

  • 12. Bactericidal activity of enoxacin and lomefloxacin against Escherichia coli KL16.
    Lewin CS, Amyes SG, Smith JT.
    Eur J Clin Microbiol Infect Dis; 1989 Aug; 8(8):731-3. PubMed ID: 2506044
    [Abstract] [Full Text] [Related]

  • 13. Bactericidal activity of trovafloxacin (CP-99,219).
    Morrissey I.
    J Antimicrob Chemother; 1996 Dec; 38(6):1061-6. PubMed ID: 9023654
    [Abstract] [Full Text] [Related]

  • 14. Antibacterial activity of quinolones against coagulase-negative staphylococci and the quinolone resistance-determining region of the gyrA genes from six species.
    Takahata M, Yonezawa M, Matsubara N, Watanabe Y, Narita H, Matsunaga T, Igarashi H, Kawahara M, Onodera S, Oishi Y.
    J Antimicrob Chemother; 1997 Sep; 40(3):383-6. PubMed ID: 9338491
    [Abstract] [Full Text] [Related]

  • 15. Bactericidal mechanism of gatifloxacin compared with other quinolones.
    Gradelski E, Kolek B, Bonner D, Fung-Tomc J.
    J Antimicrob Chemother; 2002 Jan; 49(1):185-8. PubMed ID: 11751786
    [Abstract] [Full Text] [Related]

  • 16. In vitro antimicrobial activity of fluoroquinolones against clinical isolates obtained in 1989 and 1990.
    Chen YC, Chang SC, Hsu LY, Hsieh WC, Luh KT.
    J Formos Med Assoc; 1993 Dec; 92(12):1040-8. PubMed ID: 7911351
    [Abstract] [Full Text] [Related]

  • 17. In-vitro slime production by Staphylococcus epidermidis in presence of subinhibitory concentrations of ciprofloxacin, ofloxacin and sparfloxacin.
    Pérez-Giraldo C, Rodríguez-Benito A, Morán FJ, Hurtado C, Blanco MT, Gómez-García AC.
    J Antimicrob Chemother; 1994 Apr; 33(4):845-8. PubMed ID: 8056703
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of the bactericidal activity of moxifloxacin and levofloxacin against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli and Klebsiella pneumoniae.
    Lemmen SW, Häfner H, Klik S, Lütticken R, Zolldann D.
    Chemotherapy; 2003 May; 49(1-2):33-5. PubMed ID: 12714807
    [Abstract] [Full Text] [Related]

  • 19. [Bactericidal action of lomefloxacin a new pyridonecarboxylic acid derivative].
    Koikeda S, Okabe H, Shibata H, Hase T, Nakanishi N, Okezaki E, Kato H, Masamune Y.
    Jpn J Antibiot; 1989 Jan; 42(1):193-9. PubMed ID: 2468799
    [Abstract] [Full Text] [Related]

  • 20. Effect of phagocytosis of bacteria on the uptake of sparfloxacin by human neutrophils.
    García I, Pascual A, Ballesta S, Perea EJ.
    Chemotherapy; 1996 Jan; 42(6):465-7. PubMed ID: 8957582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.